GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Camp4 Therapeutics Corp (NAS:CAMP) » Definitions » Price-to-Owner-Earnings

CAMP (Camp4 Therapeutics) Price-to-Owner-Earnings : (As of May. 13, 2025)


View and export this data going back to 2024. Start your Free Trial

What is Camp4 Therapeutics Price-to-Owner-Earnings?

As of today (2025-05-13), Camp4 Therapeutics's share price is $2.10. Camp4 Therapeutics does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Camp4 Therapeutics's Price-to-Owner-Earnings or its related term are showing as below:


CAMP's Price-to-Owner-Earnings is not ranked *
in the Biotechnology industry.
Industry Median: 28.43
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2025-05-13), Camp4 Therapeutics's share price is $2.10. Camp4 Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2024 was $-1.35. Therefore, Camp4 Therapeutics's PE Ratio (TTM) for today is At Loss.

As of today (2025-05-13), Camp4 Therapeutics's share price is $2.10. Camp4 Therapeutics's EPS without NRI for the trailing twelve months (TTM) ended in was $-1.35. Therefore, Camp4 Therapeutics's PE Ratio without NRI for today is At Loss.


Camp4 Therapeutics Price-to-Owner-Earnings Historical Data

The historical data trend for Camp4 Therapeutics's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Camp4 Therapeutics Price-to-Owner-Earnings Chart

Camp4 Therapeutics Annual Data
Trend Dec22 Dec23 Dec24
Price-to-Owner-Earnings
- - -

Camp4 Therapeutics Quarterly Data
Dec22 Sep23 Dec23 Jun24 Sep24 Dec24
Price-to-Owner-Earnings Get a 7-Day Free Trial - - - - -

Competitive Comparison of Camp4 Therapeutics's Price-to-Owner-Earnings

For the Biotechnology subindustry, Camp4 Therapeutics's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Camp4 Therapeutics's Price-to-Owner-Earnings Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Camp4 Therapeutics's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Camp4 Therapeutics's Price-to-Owner-Earnings falls into.


;
;

Camp4 Therapeutics Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Camp4 Therapeutics's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.10/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Camp4 Therapeutics  (NAS:CAMP) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Camp4 Therapeutics Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Camp4 Therapeutics's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Camp4 Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
One Kendall Square, Building 1400 West, 3rd Floor, Cambridge, MA, USA
Camp4 Therapeutics Corp is a clinical stage biopharmaceutical company pioneering the discovery and development of regulatory RNA-based therapeutics to upregulate gene expression and restore healthy protein levels to treat various genetic diseases. It focuses on genetic diseases of the central nervous system and liver. The group's pipeline products are CMP-CPS-001 and CMP-SYNGAP.